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The value of comparative genomics in understanding
mycobacterial virulence: Mycobacterium tuberculosis H37Ra
genome sequencing – a worthwhile endeavour
If the importance of a disease for mankind is measured by the number of fatalities it causes, then 
tuberculosis must be considered much more important than those most feared infectious diseases, plague, 
cholera and the like. If one only considers the productive middle-age groups, tuberculosis carries away 
one-third, and often more.
Robert Koch, 24 March 1882
It is indeed tragic that these words holds true to this day; nearly one-third of the world’s population is 
latently infected with Mycobacterium tuberculosis and the annual TB death toll is ~2 million (Corbett 
et al 2003). Robert Koch established the etiology of TB in 1882 and the much debated but widely used 
BCG (bacille Calmette-Guérin) vaccine was developed in 1921. Several compounds with anti-TB activity 
were introduced as therapeutics during 1943 to 1963 and it was anticipated that this would mark the 
rapid exit of TB as a public health challenge (Ramakrishnan and Chandrashekhar 1999). However, the 
ability of M. tuberculosis to persist indefi nitely in tissues in a metabolically quiescent state requires the 
implementation of long treatment regimens. This makes patient compliance diffi cult, leading to treatment 
failure and the emergence of drug resistant strains. Another attribute of persistent organisms, which poses 
a great obstacle to the world wide control and eradication of TB, is that the non-replicating bacilli may 
be in a state of ‘drug indifference’ wherein they are not killed by drugs (Wayne and Sohaskey 2001). 
Our understanding of the physiology of the persistor bacilli has improved in recent years thanks to the 
development of in vitro models, generation of mutant M. tuberculosis strains, global gene expression 
analysis and to the increasing availability of various mycobacterial whole genome sequences (Tyagi and 
Sharma 2004). Based on our improved understanding, novel approaches are being attempted to target the 
persistor bacterial population.
In this post-genomic era, now more than ever before, an understanding of strain-to-strain variation is 
expected to fast-forward the rational design and development of effective diagnostic reagents, vaccines 
and drugs in the case of the ‘diffi cult-to-crack’ TB pathogen. Therefore, not surprisingly the present era of 
mycobacterial genomics is rapidly evolving into a period of comparative genomics and transcriptomics. 
In comparative genomics, sequence data of related species are scrutinized from the perspective of 
correlating differences in the physiology, biochemistry and virulence with those found at the genetic 
level. Several genomes including two strains of M. tuberculosis (i.e. H37Rv and CDC1551), M. bovis, M. 
leprae, M. smegmatis, M. ulcerans, Mycobacterium sp. MCS, Mycobacterium sp. KMS, M. vanbaalenii 
PYR-1, M. avium and M. avium subsp. paratuberculosis have been sequenced and annotated completely 
(www.ncbi.nlm.nih.gov/genomes/lproks.cgi). Fifteen additional mycobacterial genome sequencing 
projects have either been completed and awaiting annotation or are underway. 
The elucidation of the M. tuberculosis H37Rv genome sequence is unanimously acknowledged to be 
a landmark achievement in that it provided the fi rst truly global insight into the tubercle bacillus (Cole et 
al 1998). However, given that M. tuberculosis H37Rv is a classical laboratory reference strain that has 
been passaged for many decades outside the human host, there were concerns relating to how accurately 
its sequence refl ected the pathogenic potential of tubercle bacilli. This led to the sequencing of the
M. tuberculosis CDC1551 genome (also known as the Oshkosh or CSU93 strain), a clinical isolate from a 
rural area in the United States (Fleischmann et al 2002). Although there has been some controversy over 
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whether or not the CDC1551 strain is more virulent than other strains in animals, it was demonstrated 
to show increased transmissibility and greater immunoreactivity (Bishai et al 1999). Comparison of 
the CDC1551 and H37Rv genome sequences revealed a number of notable differences (table 1). The 
high levels of polymorphism disproved the earlier notion that there is little sequence variation in M. 
tuberculosis. Four gene families including the Pro-Glu/Pro-Pro-Glu (PE/PPE) family showed higher 
substitution frequency than that observed for the genome as a whole, warranting further investigation into 
their role in virulence or immunogenicity. 
Analysis of the genome sequence of the causative agent of leprosy, M. leprae, revealed an extreme case 
of reductive evolution (Cole et al 2001). Its genome contains only ~ 40% of the genes in comparison to
M. tuberculosis H37Rv, leading to the loss of many important metabolic functions (table 1). While 
preserving genes required for its transmission, establishment and survival in the host, M. leprae has 
discarded genes that can be compensated for by a host-dependent parasitic lifestyle. Analysis of the
M. leprae genome therefore provided an explanation for its obligate intracellularism and inability to grow 
in vitro.
A recent addition to the list of annotated complete mycobacterial genomes is that of M. bovis 
AF2122/97 (table 1), which causes TB in a range of animal species and also in man (Garnier et al 2003). 
Strikingly, its genome sequence is >99.95% identical to that of M. tuberculosis and comparison with 
M. leprae reveals a number of common gene losses, suggesting the removal of functional redundancy. 
Cell wall components and secreted proteins showed the maximum variation suggesting their potential 
relevance in host-pathogen interaction or immune evasion (Garnier et al 2003). Furthermore, there are 
no genes unique to M. bovis, implying that differential gene expression may be responsible for the host 
specifi city of human and bovine bacilli. M. bovis was also the progenitor of the human BCG vaccine 
Table 1. Insights from comparative genomics with M. tuberculosis H37Rv.
Organism Strain (size) Inference deduced
M. tuberculosis 
(Fleischmann
et al 2002)
CDC1551 (4.4 Mb) CDC1551 contains 49 insertions relative to H37Rv, 35 of 
which affect ORFs
H37Rv contains 37 insertions relative to CDC1551, 26 of 
which affect ORFs
Frequency of SNPs in M. tuberculosis is lower than in other 
bacteria
4 copies of IS6110 are present in CDC1551 compared to 16 
copies in H37Rv
Polymorphic loci included a phospholipase C, a membrane 
lipoprotein, members of an adenylate cyclase family and 
members of PE/PPE gene family, some of which have been 
implicated in virulence or host immune response 
M. leprae
(Cole et al 2001)
Armadillo-derived 
Indian isolate 
(3.27 Mb)
Massive gene decay resulting in: 
–  loss of many important regulatory and metabolic 
activities including siderophore production, part of the 
oxidative and most of the microaerophillic and anaerobic 
respiratory chains, and numerous catabolic and their 
regulatory circuits
– restricted neural predilection 
M. bovis (Garnier
et al 2003)
AF2122/97
(4.35 Mb)
>99.95% identical to H37Rv; 11 regions of difference (RD), 
varying in size from ~1 to 12.7 Kb
Only one region (TbD1) absent in majority of M. tuberculosis 
strains
No unique genes, broad host range likely to be the result of 
differential gene expression
Cell wall components and secreted proteins show greatest 
variation
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strains, derived by serial passage of M. bovis in the laboratory over a 13 year period (Garnier et al 
2003). An interesting comparative genome microarray analysis between M. tuberculosis and 13 different 
M. bovis BCG strains revealed that 16 regions (named RD1 to RD16) were deleted from different
BCG genomes relative to the H37Rv genome (Behr et al 1999). Nine of the RDs (containing 61 ORFs) 
were absent from all the BCG strains as well as all virulent M. bovis strains tested. One key deletion, RD1, 
was missing from all the BCG strains but present in all other M. tuberculosis complex members including 
M. bovis. Such comparative studies between M. tuberculosis and M. bovis BCG have provided insight 
into the potential genetic basis of attenuation of BCG and also bestowed opportunities for experimentally 
examining the role of discrete genomic sequences in virulence and pathogenesis. Thus the RD1 deletion 
appears to have played a key role in the attenuation of BCG (Lewis et al 2003; Pym et al 2002). We expect 
to gain deeper insights into the mechanism of attenuation when the genome of M. bovis BCG Pasteur 
strain is analysed. 
In a similar vein, sequencing of the M. tuberculosis H37Ra genome and its comparative genomics is 
also likely to expedite the identifi cation of TB virulence factors. TB researchers have extensively worked 
with the highly attenuated H37Ra and virulent H37Rv strains of M. tuberculosis that were derived
by serial passaging of the H37 clinical isolate through laboratory media (Brosch et al 1999). However, 
the genetic basis for the avirulent phenotype of M. tuberculosis H37Ra in the animal models is not
known. Since the H37Ra strain does not revert to a virulent phenotype on passaging through animals, 
it is likely that the former has acquired multiple point mutations or small deletions/rearrangements 
in genes crucial for virulence. Despite extensive use of these strains only a few differences between 
H37Rv and H37Ra at the genetic and expression levels have been reported over the last several years. 
These include IS6110 mediated polymorphisms (Brosch et al 1999; Bifani et al 2000). Among the 
fi ve regions (RvD1-RvD5) deleted in the H37Rv genome relative to M. bovis, four (except for RvD2) 
were also absent in H37Ra (Brosch et al 1999). However, since RvD2 is present in H37Ra as well as 
in clinical isolates, this region is unlikely to be instrumental in the attenuation of H37Ra (Brosch et al 
1999). Although (in contrast to BCG) the RD1 region is intact in H37Ra, marked down regulation was 
noted for genes coding for RD1 antigenic proteins CFP10 and ESAT6 as well as neighboring genes that 
likely encode a secretion apparatus devoted to their export (Mostowy et al 2004). These results provide 
a partial explanation for H37Ra’s attenuation and reiterate the correlation between RD1 and attenuation. 
In our laboratory, we used subtractive RNA hybridization between H37Rv and H37Ra strains cultured
in vitro to isolate genes that were differentially expressed in virulent strain [dev genes] (Kinger and 
Tyagi 1993). Several genes were identifi ed which included the two-component system devR-devS 
[Rv3133c/Rv3132c; dosR/dosS] (Dasgupta et al 2000) and acr (Tyagi, unpublished data). devR was 
shown to modulate the virulence of M. tuberculosis (Malhotra et al 2004; Parish et al 2003) and to be a 
regulator of the hypoxia/NO dormancy response (Park et al 2003; Voskuil et al 2003). The underlying 
basis for the differential gene expression of devR-devS genes was not readily explained as the coding 
and promoter sequences were identical in H37Ra and H37Rv (Malhotra and Tyagi, unpublished 
data). This suggests the likelihood of a regulatory element(s) present elsewhere in the genome 
that may be altered in the avirulent H37Ra strain. The aggregation of mycobacteria into structures
known as ‘cords’ has long been associated with virulence (Middlebrook et al 1947). Comparative gene 
expression analysis recently identifi ed 22 genes that were consistently expressed at higher levels in 
H37Rv (a cording strain) than in H37Ra (a non-cording strain) under a variety of growth conditions
(Gao et al 2004). More than half of these genes were either involved in lipid metabolism or were putative 
cell membrane proteins. The difference in cell wall methyl-branched lipids indeed formed the basis 
for neutral-red positive staining for H37Rv in contrast to negative staining for H37Ra (Cardona et al
2006). Rindi et al (1999) identifi ed six genes down regulated in the H37Ra strain compared to the 
H37Rv strain, of which three code for proteins that can be predictively associated to immunological 
or pathogenetic aspects of M. tuberculosis infection. The absence of fi ve ESAT-6 like proteins from the 
culture fi ltrates of H37Ra and their presence in H37Rv has also been related to the latter’s virulence
(He et al 2003). Another crucial virulence determining factor is the ability of M. tuberculosis to infect 
and grow in human macrophages. Infected macrophages respond by undergoing apoptosis, a cornerstone 
of effective antimycobacterial host defense. However, virulent mycobacteria override this reaction by 
inducing necrosis leading to dissemination of the pathogen and development of disease (Chen et al 2006). 
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Although both H37Rv and H37Ra were able to infect macrophages equally, only H37Rv and not H37Ra 
was able to grow intracellularly as well as cause signifi cant mitochondrial damage leading to necrosis 
(Silver et al 1998; Chen et al 2006).
Elucidating the mechanism of TB pathogenesis is a central question for mycobacteriologists. 
Disease is an outcome of a delicate and dynamic balance between pathogen and host immune response.
M. tuberculosis strains generated both by random transposon mutation and targeted gene deletion 
approaches have taught us that virulence is indeed a very complex phenotype. These mutant strains 
derived by deliberate engineering in the laboratory are each defective at a single genetic locus. One of 
the surprises of H37Rv genome sequencing was the large extent of functional redundancies present (Cole 
et al 1998). Hence, it is possible that a gene disruption may not display a phenotype due to functional 
compensation by a redundant ‘backup’ gene. Sequencing H37Ra and its comparison with that of H37Rv 
is likely to reveal the functional redundancies that possibly come into play in vivo (in H37Rv) in addition 
to presenting a kaleidoscopic view of the genetic spectrum necessary for the display of the complex 
phenotype of virulence.
In view of the (i) stark differences in the virulence phenotypes of H37Rv and H37Ra strains, (ii) failure 
to detect gross differences in their nucleotide sequences, and (iii) inability to restore virulence in H37Ra 
complemented with H37Rv sequences encompassing polymorphic regions (Brosch et al 1999), the 
H37Ra genome is a worthwhile candidate for whole genome sequencing. The genome sequence will help 
to answer pressing questions related to the virulence of M. tuberculosis by enabling bioinformatics-guided 
experimentation, and also provide valuable inputs to TB vaccine and drug development endeavours. 
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